Vol 2 (August 25, 2024): AME Clinical Trials Review

Adjuvant immunotherapy in hepatocellular carcinoma: effective for Asian only, or for all patients?

Maintenance strategies in first-line treatment for RAS/BRAF wild-type metastatic colorectal cancer—one size does not fit all

Navigating the future of axillary surgery in HER2⁺ breast cancer: insights and opportunities for change

Concurrent radiotherapy with capecitabine and pyrotinib in patients with HER2-positive breast cancer and brain metastases

Chemo-immunotherapy on localized gastroesophageal/gastric adenocarcinoma—hope or delusion?

Intracranial efficacy of adagrasib in patients with KRAS G12C mutated non-small cell lung cancer (NSCLC): are results KRYSTAL clear?

Precision oncology in small-cell lung cancer: a tough nut to crack

Beyond PACIFIC: efficacy of the dual inhibition of TGF-β and PD-L1 for stage III non-small cell lung cancer concurrent chemoradiotherapy treatment

Exploring novel combinations in the treatment of relapsed ovarian cancer: the MEDIOLA trial results

Expanding the horizons of suspected acute coronary syndrome management: insights from the RAPID-CTCA trial

Combination and precision: ingredients for success in advanced gastric cancer

Can compartment-based complete mesocolic excision improve outcomes in patients with right colon cancer with metastatic D3 nodes?

Nanoparticle-based drug delivery in advanced pancreatic ductal adenocarcinoma: is it time to deliver yet?

Personalized neoantigen vaccines for patients with advanced hepatocellular carcinoma

Polo-like kinase 1 inhibitors in refractory colorectal cancer: deciphering the myth of synthetic lethality

Precision combination therapies: shaping the future management of advanced hepatocellular carcinoma?

Multisegmented fully covered esophageal stent: a step to the side

Prolonging anticoagulation after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients: still looking for the RIGHT path

Xaluritamig: a first step towards a new target, new mechanism for metastatic prostate cancer

Prediction of lymphatic invasion for patients with early gastric cancer: a review